Global Copovidone Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Function;
Granulating Agent, Retarding Agent, Film-forming Agent, Lubricant, Thickening Agent, Dispersant, Binding Agent, Emulsifying Agent, Fining Agent, and Blocking Agent.By Form;
Liquid, Powder, and Others.By Grade;
Food Grade, Pharmaceutical Grade, and Industrial Grade.By End-Use;
Food and Beverage, Cosmetics, Personal Care, Shampoo, Toothpaste, Shaving Lotion, Moisturizer, Pharmaceuticals, Ointments, Pessaries, Surgical Scrubs, Contact Lenses, and Adhesives.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Copovidone Market (USD Million), 2021 - 2031
In the year 2024, the Global Copovidone Market was valued at USD 282.94 million. The size of this market is expected to increase to USD 398.13 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.
The global copovidone market has experienced significant growth in recent years, driven by its widespread use across various industries, particularly in the pharmaceutical and healthcare sectors. Copovidone, a synthetic polymer, is primarily used as a binder, film-forming agent, and stabilizer in drug formulations, offering improved solubility and bioavailability of active pharmaceutical ingredients (APIs). Its versatility makes it a key component in the production of solid dosage forms, including tablets and capsules, where it helps in enhancing the mechanical strength and stability of the products.
The increasing demand for high-quality pharmaceutical products, along with the growing prevalence of chronic diseases, has propelled the need for efficient drug delivery systems. Copovidone is also gaining traction in the development of oral solid dosage forms, which is a major driver for the market. The global expansion of the pharmaceutical sector, especially in emerging economies, further fuels the adoption of copovidone in drug formulation, as it meets regulatory standards and ensures optimal performance in a variety of therapeutic areas.
Furthermore, the growing awareness regarding the benefits of copovidone in the production of oral dosage forms and its role in ensuring the controlled release of drugs has contributed to its demand. The cosmetic and personal care industries have also found applications for copovidone in the formulation of creams, lotions, and gels, where it serves as an emulsifier and stabilizer. As a result, the copovidone market is expected to continue expanding, driven by innovations in drug development, increased production capabilities, and the broader use of copovidone across different sectors.
Global Copovidone Market Recent Developments
-
in 2021, Glenmark Life Science, an Indian manufacturer of drugs and therapeutics products announced its plan of investing around USD 78.7 Million for increasing its production capacity to more than double in the coming years.
-
In February 2020, LASA Supergenerics Limited announced it had acquired Harishree Aromatics & Chemicals Private Limited, a leading player engaged in the manufacturing of veterinary APIs and other pharmaceutical intermediates. The move is anticipated to help the company meet the rising demand for povidone iodine in Asia Pacific.
Segment Analysis
The copovidone market is segmented based on its various functions, including granulating agent, retarding agent, film-forming agent, and others, each serving specific purposes in drug formulations and other industries. As a granulating agent, copovidone helps in binding ingredients together to form solid dosage forms, while its role as a film-forming agent is vital in coating tablets and capsules. In addition, as a retarding agent, it controls the release of active ingredients, making it crucial in controlled-release formulations. Copovidone also acts as a lubricant, thickening agent, dispersant, emulsifying agent, and fining agent in different applications, allowing for enhanced stability and performance in a wide range of products.
The market is also categorized by form, with copovidone available in liquid, powder, and other formats, catering to the specific requirements of various industries. The powder form is predominantly used in pharmaceutical applications, where it is incorporated into solid dosage forms, while the liquid form is often preferred in cosmetics and personal care products for its ease of use and mixing with other ingredients. The versatility of copovidone in different forms allows it to be widely adopted across diverse industries, providing manufacturers with flexibility in product development.
Further segmentation includes the grade of copovidone, with three primary categories: food grade, pharmaceutical grade, and industrial grade. Pharmaceutical grade copovidone is subject to the highest standards for purity and quality, ensuring safety and efficacy in drug formulations. Food-grade copovidone is used in the food and beverage industry, particularly in food coatings and as a stabilizer. Industrial-grade copovidone, which has lower purity standards, is typically utilized in non-consumer applications, such as adhesives and coatings. The market is also geographically segmented, with North America, Europe, and Asia Pacific being major regions driving demand, supported by growing industries and technological advancements. The Middle East, Africa, and Latin America also present opportunities for market expansion as the demand for copovidone in pharmaceuticals and personal care products continues to rise.
Global Copovidone Segment Analysis
In this report, the Global Copovidone Market has been segmented by Function, Form, Grade, End-Use and Geography.
Global Copovidone Market, Segmentation by Function
The Global Copovidone Market has been segmented by Function into Granulating Agent, Retarding Agent, Film-forming Agent, Lubricant, Thickening Agent, Dispersant, Binding Agent, Emulsifying Agent, Fining Agent and Blocking Agent.
The copovidone market is segmented by its diverse functional applications, which are essential across various industries. As a granulating agent, copovidone plays a pivotal role in binding ingredients to form cohesive granules, improving the flowability and compressibility of powders, which is vital in pharmaceutical tablet production. In its capacity as a retarding agent, copovidone is used to control the release rate of active pharmaceutical ingredients, making it an important component in controlled and sustained-release drug formulations. Additionally, copovidone’s film-forming ability is highly valued in coating applications, especially for tablet and capsule production, where it ensures the protection of the active ingredients while also enhancing their aesthetic appeal.
The market also utilizes copovidone as a lubricant, thickening agent, and dispersant. In drug formulation, copovidone works as a lubricant to ease the processing and handling of powders, especially during tablet compression. As a thickening agent, it enhances the viscosity of liquids, which is useful in both pharmaceuticals and personal care products. Furthermore, copovidone’s dispersing properties are essential in ensuring uniform distribution of active ingredients in solid and liquid formulations, contributing to product consistency and effectiveness. Its emulsifying role helps blend ingredients that would not normally mix, such as oil and water, making it valuable in the production of creams, lotions, and other cosmetic products.
Copovidone also functions as a binding agent, which is crucial in holding together tablet ingredients and ensuring tablet integrity. As an emulsifying agent, it aids in stabilizing emulsions, preventing phase separation in products like creams and ointments. The fining agent function of copovidone is important in the clarification of liquids, particularly in the food and beverage industry, where it helps remove impurities, ensuring clear and refined products. Finally, in certain applications, copovidone is used as a blocking agent to prevent unwanted reactions in chemical processes or to protect sensitive ingredients from degradation. These various functions across multiple sectors drive the demand for copovidone, further solidifying its position as a versatile excipient.
Global Copovidone Market, Segmentation by Form
The Global Copovidone Market has been segmented by Form into Liquid, Powder and Others.
The copovidone market is segmented by form into liquid, powder, and other variants, each catering to specific industry needs. The liquid form of copovidone is commonly used in the cosmetic and personal care industries, where it is incorporated into formulations such as lotions, creams, and shampoos. Its ability to blend easily with other ingredients makes it ideal for applications that require smooth texture and enhanced stability. In these products, copovidone serves as an emulsifier, binder, and stabilizer, ensuring consistency and performance across different types of formulations.
The powder form of copovidone is the most prevalent in the pharmaceutical sector, where it is predominantly used as a binder, film-forming agent, and stabilizer in solid dosage forms such as tablets and capsules. This form is also critical in drug delivery systems, including controlled-release formulations, where copovidone helps control the rate of drug release. Its fine powder consistency makes it easier to incorporate into tablet formulations, ensuring uniformity and quality of the final product. Pharmaceutical-grade powder copovidone meets stringent regulatory standards, ensuring safety and efficacy for medical use.
In addition to liquid and powder forms, copovidone is also available in other formats, such as granules or gels, depending on the specific application requirements. These forms provide versatility in formulation, especially when manufacturers seek specific properties like enhanced solubility, texture, or ease of handling. The availability of copovidone in different forms allows it to serve a wide range of industries, from pharmaceuticals and cosmetics to food and beverages, expanding its usage and market potential.
Global Copovidone Market, Segmentation by Grade
The Global Copovidone Market has been segmented by Grade into Food Grade, Pharmaceutical Grade and Industrial Grade.
The copovidone market is further segmented by grade, including food grade, pharmaceutical grade, and industrial grade, each tailored to meet specific industry standards and applications. Food-grade copovidone is used primarily in the food and beverage sector, where it serves as a stabilizer, emulsifier, or film-forming agent in various products such as food coatings and processing aids. This grade ensures that copovidone meets the necessary safety standards for consumption, focusing on non-toxic and safe ingredients, while providing functional benefits like enhancing texture and extending shelf life.
Pharmaceutical-grade copovidone is held to the highest purity and quality standards, making it suitable for use in drug formulations. It is commonly used as a binder, stabilizer, and film-forming agent in solid dosage forms such as tablets and capsules. Pharmaceutical-grade copovidone is rigorously tested to ensure that it does not interfere with the efficacy of active pharmaceutical ingredients and complies with strict regulatory guidelines set by authorities like the FDA and EMA. This grade is crucial for ensuring the safety, effectiveness, and reliability of pharmaceutical products.
Industrial-grade copovidone, which is characterized by a lower purity level than pharmaceutical-grade, is typically used in non-consumer applications. It finds uses in industries such as adhesives, coatings, and textiles, where the functional properties of copovidone—such as binding and film formation—are required but without the need for the high level of purity mandated in food or pharmaceutical products. Industrial-grade copovidone is cost-effective for large-scale production in these sectors, offering value while meeting the basic performance criteria for manufacturing processes.
Global Copovidone Market, Segmentation by End-Use
The Global Copovidone Market has been segmented by End-Use into Food and Beverage, Cosmetics, Personal Care, Shampoo, Toothpaste, Shaving Lotion, Moisturizer, Pharmaceuticals, Ointments, Pessaries, Surgical Scrubs, Contact Lenses and Adhesives.
The copovidone market is segmented by end-use across various industries, with its versatile properties making it valuable in numerous applications. In the food and beverage sector, copovidone is used primarily as an emulsifier, stabilizer, and film-forming agent in products such as food coatings and processing aids. Its ability to enhance texture and improve shelf life has driven its demand in the food industry, ensuring that products maintain consistency and quality throughout distribution and storage.
In cosmetics and personal care products, copovidone serves multiple functions, including as an emulsifying agent and stabilizer in shampoos, conditioners, shaving lotions, moisturizers, and toothpaste. Its ability to create smooth, uniform formulations makes it essential in these products, where texture, stability, and performance are critical. Copovidone helps in the easy dispersion of ingredients, improves product consistency, and ensures a pleasant user experience in personal care items, particularly those applied directly to the skin or hair.
Copovidone’s role in pharmaceuticals is significant, where it is used as a binder, stabilizer, and film-forming agent in formulations like ointments, pessaries, and surgical scrubs. It helps in the controlled release of active ingredients in drug delivery systems, ensuring effective therapeutic outcomes. Additionally, copovidone is utilized in the production of contact lenses, where it serves as a coating agent, improving lens comfort and durability. In the adhesives industry, copovidone is used for its binding and film-forming properties, contributing to the development of high-performance adhesives for industrial applications. These diverse end-uses highlight copovidone’s adaptability across various sectors, ensuring its continued relevance and demand.
Global Copovidone Market, Segmentation by Geography
In this report, the Global Copovidone Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Copovidone Market Share (%), by Geographical Region, 2024
The copovidone market is geographically segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, with each region displaying unique demand drivers and market trends. North America, particularly the United States, is a dominant region due to its well-established pharmaceutical and personal care industries. The region's stringent regulatory standards ensure high demand for pharmaceutical-grade copovidone in drug formulations, while the growing personal care market drives the need for copovidone in cosmetic and skincare products. The strong presence of key pharmaceutical companies and continuous innovations in drug delivery systems further contribute to the region's market growth.
Europe is another key region for the copovidone market, driven by its highly developed pharmaceutical sector and stringent regulatory environment. The European market benefits from advancements in drug development and the increasing demand for high-quality excipients in drug formulations. Furthermore, the expanding cosmetics and personal care industries in countries like Germany, France, and Italy increase the demand for copovidone in products such as lotions, shampoos, and moisturizers. Europe’s commitment to research and development, coupled with its growing healthcare infrastructure, supports the continued adoption of copovidone in various applications.
The Asia Pacific region is experiencing significant growth in the copovidone market, driven by the rising demand for pharmaceuticals and personal care products in emerging economies like China and India. With expanding manufacturing capabilities, cost-effective production, and increasing healthcare investments, Asia Pacific presents substantial opportunities for market expansion. The region’s growing population and rising disposable income are contributing to a higher demand for consumer goods, including food, beverages, and cosmetics, where copovidone is used as a stabilizer and emulsifier. The Middle East and Africa, along with Latin America, are also expected to see steady market growth, driven by increasing healthcare spending, improved manufacturing capabilities, and growing consumer demand for personal care products and pharmaceuticals in these regions.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Copovidone Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing demand for effective drug delivery systems
- Growth in pharmaceutical and healthcare sectors
- Rising prevalence of chronic diseases
-
Regulatory approval for use in drug formulations-Regulatory approval for the use of copovidone in drug formulations is a crucial driver for its adoption in the pharmaceutical industry. Regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national authorities evaluate the safety, efficacy, and quality of pharmaceutical excipients like copovidone before they can be used in drug products. These approvals ensure that copovidone meets the necessary standards for use in solid dosage forms, such as tablets and capsules, where it functions as a binder, stabilizer, or film-forming agent. Compliance with these regulatory requirements is vital for manufacturers to bring their products to market and meet consumer and patient expectations for safety and reliability.
Moreover, the growing acceptance and recognition of copovidone as a safe excipient by regulatory agencies have facilitated its widespread incorporation into drug formulations. As regulatory frameworks evolve, they support the continued use of copovidone in new drug delivery systems, especially those designed to enhance bioavailability and control drug release. This regulatory validation helps to build trust within the pharmaceutical industry, ensuring that copovidone continues to be a valuable component in the development of advanced therapies.
Restraints:
- High manufacturing costs of copovidone
- Limited availability of raw materials
-
Stringent regulatory requirements-Stringent regulatory requirements pose a significant restraint in the copovidone market. Regulatory bodies like the FDA, EMA, and other global agencies enforce strict guidelines for the approval of excipients used in drug formulations, including copovidone. These requirements ensure that the substance is safe, effective, and consistent in its performance across various drug products. However, the complexity of meeting these regulations can lead to longer approval timelines and higher costs for manufacturers.
Additionally, the need for extensive clinical trials, toxicological studies, and batch-to-batch consistency testing adds to the regulatory burden. Companies must invest substantial resources in research and development, compliance documentation, and quality control to meet the ever-evolving standards set by authorities. While these measures are essential for ensuring patient safety, they can be a barrier for new entrants or small manufacturers trying to establish themselves in the market.
Opportunities:
- Expansion in emerging markets
- Growing applications in the cosmetic industry
- Development of new drug formulations
-
Technological advancements in copovidone production-Technological advancements in copovidone production have significantly contributed to the growth and efficiency of the market. Innovations in manufacturing processes, such as improved polymerization techniques and the use of advanced equipment, have led to higher yields, reduced production costs, and enhanced product quality. These advancements allow manufacturers to produce copovidone with greater consistency and purity, meeting stringent industry standards and regulatory requirements.
Furthermore, advancements in the optimization of the polymer’s molecular structure have improved its functional properties, such as solubility, stability, and film-forming ability, making it more effective in various pharmaceutical applications. The development of more efficient synthesis methods has also led to a reduction in the environmental impact of copovidone production, addressing sustainability concerns within the industry. As new production techniques emerge, manufacturers are better equipped to meet the growing demand for copovidone in drug formulations, especially in the context of increasingly complex drug delivery systems.
Competitive Landscape Analysis
Key players in Global Copovidone Market include,:
- Ashland
- BASF
- JH Nanhang
- BOC Sciences
- Resonac Corporation
- JRS Pharma
- Clinivex
- Glentham Life Sciences
- Markan Global Enterprises
- VIVAN Life Sciences
- BOAI NKY MEDICAL HOLDINGS LTD
- Star-Tech & JRS Specialty Products Co., Ltd
- GUANGDONG YUMAY CHEMICAL CO., LTD
- Hangzhou Sunflower Technology Development Co., Ltd
- SHANGHAI YUKING WATER SOLUBLE MATERIAL TECH CO., LTD
- Shanghai Dexiang Medicine Tech Co., Ltd
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Function
- Market Snapshot, By Form
- Market Snapshot, By Grade
- Market Snapshot, By End-Use
- Market Snapshot, By Region
- Global Copovidone Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing demand for effective drug delivery systems
- Growth in pharmaceutical and healthcare sectors
- Rising prevalence of chronic diseases
- Regulatory approval for use in drug formulations
- Restraints
- High manufacturing costs of copovidone
- Limited availability of raw materials
- Stringent regulatory requirements
- Opportunities
- Expansion in emerging markets
- Growing applications in the cosmetic industry
- Development of new drug formulations
- Technological advancements in copovidone production
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Copovidone Market, By Function, 2021 - 2031(USD Million)
- Granulating Agent
- Retarding Agent
- Film-forming Agent
- Lubricant
- Thickening Agent
- Dispersant
- Binding Agent
- Emulsifying Agent
- Fining Agent
- Blocking Agent
- Global Copovidone Market, By Form, 2021 - 2031 (USD Million)
- Liquid
- Powder
- Others
- Global Copovidone Market, By Grade, 2021 - 2031 (USD Million)
- Food Grade
- Pharmaceutical Grade
- Industrial Grade
- Global Copovidone Market, By End-Use, 2021 - 2031 (USD Million)
- Food and Beverage
- Cosmetics
- Personal Care
- Shampoo
- Toothpaste
- Shaving Lotion
- Moisturizer
- Pharmaceuticals
- Ointments
- Pessaries
- Surgical Scrubs
- Contact Lenses
- Adhesives
- Global Copovidone Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Rest of Europe
- Benelux
- Nordic
- Spain
- Italy
- France
- United Kingdom
- Germany
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Copovidone Market, By Function, 2021 - 2031(USD Million)
- Competitive Landscape
- Company Profiles
- Ashland
- BASF
- JH Nanhang
- BOC Sciences
- Resonac Corporation
- JRS Pharma
- Clinivex
- Glentham Life Sciences
- Markan Global Enterprises
- VIVAN Life Sciences
- BOAI NKY MEDICAL HOLDINGS LTD
- Star-Tech & JRS Specialty Products Co., Ltd
- GUANGDONG YUMAY CHEMICAL CO., LTD
- Hangzhou Sunflower Technology Development Co., Ltd
- SHANGHAI YUKING WATER SOLUBLE MATERIAL TECH CO., LTD
- Shanghai Dexiang Medicine Tech Co., Ltd
- Company Profiles
- Analyst Views
- Future Outlook of the Market